With a market valuation of Rs. 30.34 crore, Shukra Pharmaceuticals Ltd. is a small-cap company operating in the pharmaceutical industry. Public Ltd Shukra Pharmaceuticals has well-known manufacturing facilities around the world. Since 2017, the company has been manufacturing pharmaceutical products such as tablets, capsules and injections. The company’s board of directors proposes a final dividend of 5% (0.50 Rs per equity share at par value of Rs 10), subject to Shareholders’ approval at the General Meeting the next annual shareholder meeting, at their meeting to be held on May 28, 2022.